Letter: Encouraging genetic research
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Sir: It is wrong to claim that there is a hidden loophole in the proposed European biotechnology directive which would allow "new rights over human genes" (report, 27 August). There is already legislation in place within the European Patents Convention which allows patenting of genes if they have been isolated from the body or produced by a technical process and if the normal criteria of patentability can be demonstrated.
Rather than prevent scientific research, as you suggest, the proposed directive will actually encourage it. The benefit of the patent system is that the inventor must publish sufficient detail to enable fellow researchers to undertake their own research.
The intention of the directive will be to harmonise legislation on patents across Europe. It will help British industry, which already leads Europe in the field of biotechnology, to earn a fair reward from its search for new medicines for many as yet unconquered diseases and bring hope to many millions of patients.
The directive has been discussed at length within six expert committees of the European Parliament, and more than 450 amendments have been debated for more than a year before the recent EU plenary vote - hardly a process in which clauses have been buried as you describe.
Professor TREVOR M JONES
Director-General
The Association of the British Pharmaceutical Industry
London SW1
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments